BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23519513)

  • 1. A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation.
    Matikas A; Tzannou I; Oikonomopoulou D; Bakiri M
    BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23519513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of atypical chronic myeloid leukemia associated with t(8;22)(p11.2;q11.2)/ BCR-FGFR1 rearrangement: A case report and literature review.
    Washburn E; Bayerl MG; Ketterling RP; Malysz J
    Cancer Genet; 2021 Nov; 258-259():69-73. PubMed ID: 34551378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
    Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
    Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
    Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
    Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
    Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N
    Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995
    [No Abstract]   [Full Text] [Related]  

  • 7. Functional characterization of two rare BCR-FGFR1
    Barnes EJ; Leonard J; Medeiros BC; Druker BJ; Tognon CE
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 31980503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
    Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
    Konishi Y; Kondo T; Nakao K; Asagoe K; Otsuka Y; Nishikori M; Hishizawa M; Yamashita K; Takaori-Kondo A
    Bone Marrow Transplant; 2019 Feb; 54(2):326-329. PubMed ID: 30087462
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
    Dolan M; Cioc A; Cross NC; Neglia JP; Tolar J
    Pediatr Blood Cancer; 2012 Jul; 59(1):194-6. PubMed ID: 22106025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature.
    Kim SY; Oh B; She CJ; Kim HK; Jeon YK; Shin MG; Yoon SS; Lee DS
    Leuk Res; 2011 May; 35(5):e30-4. PubMed ID: 21239058
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation.
    Chen X; Huang L; Zheng C; Wang Z
    Hematology; 2021 Dec; 26(1):691-696. PubMed ID: 34493159
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11).
    Wang T; Wang Z; Zhang L; Wen L; Cai W; Yang X; Pan J; Ruan C; Wu D; Sun A; Chen S
    Br J Haematol; 2020 Jan; 188(1):177-181. PubMed ID: 31802477
    [No Abstract]   [Full Text] [Related]  

  • 15. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
    Agerstam H; Järås M; Andersson A; Johnels P; Hansen N; Lassen C; Rissler M; Gisselsson D; Olofsson T; Richter J; Fan X; Ehinger M; Fioretos T
    Blood; 2010 Sep; 116(12):2103-11. PubMed ID: 20554971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
    Demiroglu A; Steer EJ; Heath C; Taylor K; Bentley M; Allen SL; Koduru P; Brody JP; Hawson G; Rodwell R; Doody ML; Carnicero F; Reiter A; Goldman JM; Melo JV; Cross NC
    Blood; 2001 Dec; 98(13):3778-83. PubMed ID: 11739186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation.
    Peiris MN; Meyer AN; Nelson KN; Bisom-Rapp EW; Donoghue DJ
    Haematologica; 2020 May; 105(5):1262-1273. PubMed ID: 31439673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
    Wakim JJ; Tirado CA; Chen W; Collins R
    Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.
    Murati A; Arnoulet C; Lafage-Pochitaloff M; Adélaide J; Derré M; Slama B; Delaval B; Popovici C; Vey N; Xerri L; Mozziconacci MJ; Boulat O; Sainty D; Birnbaum D; Chaffanet M
    Int J Oncol; 2005 Jun; 26(6):1485-92. PubMed ID: 15870860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute leukemia showing t(8;22)(p11;q11), myelodysplasia, CD13/CD33/CD19 expression and immunoglobulin heavy chain gene rearrangement.
    Shimanuki M; Sonoki T; Hosoi H; Watanuki J; Murata S; Mushino T; Kuriyama K; Tamura S; Hatanaka K; Hanaoka N; Nakakuma H
    Acta Haematol; 2013; 129(4):238-42. PubMed ID: 23328683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.